2018
DOI: 10.3390/ijms19020348
|View full text |Cite
|
Sign up to set email alerts
|

Cytoprotective Mechanisms in Fatty Liver Preservation against Cold Ischemia Injury: A Comparison between IGL-1 and HTK

Abstract: Institute Goeorges Lopez 1 (IGL-1) and Histidine-Tryptophan-Ketoglutarate (HTK) preservation solutions are regularly used in clinical for liver transplantation besides University of Wisconsin (UW) solution and Celsior. Several clinical trials and experimental works have been carried out comparing all the solutions, however the comparative IGL-1 and HTK appraisals are poor; especially when they deal with the underlying protection mechanisms of the fatty liver graft during cold storage. Fatty livers from male ob… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 17 publications
(18 citation statements)
references
References 32 publications
0
18
0
Order By: Relevance
“…Autophagy has two paradoxically opposite behaviors, depending on the stage of the I/R condition: during ischemia, certain levels of autophagy are cytoprotective[ 35 ], but during reperfusion it is detrimental[ 32 , 33 ]. One of the key elements that regulate autophagy is the mammalian target of rapamycin (mTOR), an autophagy inhibitor.…”
Section: Aldh2 and Autophagymentioning
confidence: 99%
“…Autophagy has two paradoxically opposite behaviors, depending on the stage of the I/R condition: during ischemia, certain levels of autophagy are cytoprotective[ 35 ], but during reperfusion it is detrimental[ 32 , 33 ]. One of the key elements that regulate autophagy is the mammalian target of rapamycin (mTOR), an autophagy inhibitor.…”
Section: Aldh2 and Autophagymentioning
confidence: 99%
“…The gold standard preservation solutions used in liver transplantation have been the UW and HTK. Recently, the need to have new alternatives has opened the field to new solutions, such as Celsior and Institut Georges Lopez 1, but researchers do not completely agree regarding which one provides better short‐term and longterm outcomes . Although there are a significant number of research projects going on, there is still a lack of evidence supporting the development of new alternatives that will not only improve results but also will allow us to extend the required times for the engraftment.…”
Section: Discussionmentioning
confidence: 94%
“…Recently, the need to have new alternatives has opened the field to new solutions, such as Celsior and Institut Georges Lopez 1, but researchers do not completely agree regarding which one provides better short-term and longterm outcomes. (29)(30)(31)(32)(33)(34)(35) Although there are a significant number of research projects going on, there is still a lack of evidence supporting the development of new Original article | 1383 alternatives that will not only improve results but also will allow us to extend the required times for the engraftment. This possibility will clearly improve quality of life for the surgical time, result for the recipients, and availability of organs, as well as perhaps the costs.…”
Section: Discussionmentioning
confidence: 99%
“…We might suspect that the differences found in ALDH2/4-HNE levels may be associated with the presence/absence of the oncotic agent PEG35. This theory is supported by the fact that the presence or absence of PEG35-rinse solutions for liver grafts protects against mitochondrial damage [ 41 , 42 ], and by the comparison of IGL-1 (with PEG35) vs. HTK (without PEG35) in fatty liver graft preservation [ 43 ]. Moreover, recent preliminary research comparing IGL-1 with the same solution without oncotic agent PEG35 (IGL-0) found that the absence of PEG35 significantly reduced the fatty liver graft protection against ischemic insult after 24 h at 4 °C [ 44 ].…”
Section: Discussionmentioning
confidence: 99%